Code | 9706A | ||||||||||
MA number | EU/1/06/374/003 | ||||||||||
Product Form: | sol inj 1x0,165 ml ml/1,65 mg (striek.inj.napl.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Novartis Europharm Limited, Ireland | ||||||||||
Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravitreal use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 22.01.2007 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | DHCP Lucentis 10 5 2011.pdf |
Dokument: | DHCP Lucentis 22 2 2011.pdf |
Dokument: | Ranibizumab_Prirucka pre pacientov.pdf |
Safety feature | Yes |
Data update: | 19.06.2018 |